• Viewed 10,240 times by 3014 users (Last 30 days)
  • print Created with Sketch. Print
ALC
Click for more information
3.23% 6.0¢

ALCIDION GROUP LIMITED - Announcements

Market Cap $72.51M  ! watchlist Created with Sketch. Add to my watchlist

Alcidion Group Limited is a healthcare technology company. The Company's principal... Alcidion Group Limited is a healthcare technology company. The Company's principal activities include the development and licensing of its own healthcare software products (Miya Precision and its associated modules, including Miya Observations, Flow, Task Management and PAS), the reselling of selected healthcare software products from its strategic partners and the delivery of product implementation, product support and maintenance, systems integration, and data analysis services to healthcare customers in Australia, New Zealand, and the United Kingdom. Its product, Miya Precision, is a smart clinical solution based on a FHIR-event platform that facilitates multiple clinical and operational applications. The Company's other products include Smartpage, Patientrack, and Silverlink PCS. Smartpage is an advanced smartphone and Web-based system for hospital communication and task management, addressing the requirements of both clinical and non-clinical users. More

Corporate Spotlight
Not Yet Available

Are you a Company Director ?
Put your Investment Case to Hotcopper's 700K monthly unique visitors.

Claim your IR profile arrow Created with Sketch.
See benefits

Announcements


Plus500
Plus500
ANNOUNCEMENT SPONSORED BY PLUS500
ANNOUNCEMENT SPONSORED BY PLUS500
CFD TRADING PLATFORM
CFD Service. Your Capital is at risk
CFD TRADING PLATFORM CFD Service. Your Capital is at risk
TRADE NOW
TRADE NOW
Plus500
ANNOUNCEMENT SPONSORED BY PLUS500
CFD TRADING PLATFORM CFD Service. Your Capital is at risk
TRADE NOW

Filter Results
All Price Sensitive Only
search Created with Sketch. Search
search Created with Sketch. Search
ALC Becoming a substantial holder23/12/16
ALC Alcidion - Investor Relations Research16/12/16
ALC Alcidion Executive Director Interview With FNN14/12/16
ALC Coffs Habour Health Campus goes live with iCVISPRICE SENSITIVE13/12/16
ALC Alcidion Change of Share Registry Address12/12/16
ALC Change of Director's Interest Notice06/12/16
ALC Appendix 3B06/12/16
ALC Final Director's Interest Notice01/12/16
ALC Alcidion Results of AGM29/11/16
ALC Alcidion AGM presentation29/11/16
ALC Chairman's Letter 201629/11/16
ALC Company Secretary Appointment29/11/16
ALC Details of Company Address29/11/16
ALC Alcidion to present at ASX CEO Sessions28/11/16
ALC Alcidion Presents at Wilsons Investor Event24/11/16
ALC Alcidion TechKnow Investor Roadshow Interview17/11/16
ALC Alcidion HiNZ presentation live on Website16/11/16
ALC Alcidion Showcase at Blue Sky Annual Investor Day16/11/16
ALC Alcidion to Release shares from escrow10/11/16
ALC Alcidion to Meet with WA Health Minister07/11/16
ALC Alcidion to Conduct WA Roadshow07/11/16
ALC Notice of Annual General Meeting/Proxy Form-ALC.AX 26/10/16
ALC TechKnow Invest Roadshow Recording-ALC.AX 26/10/16
ALC Alcidion to present at Health Informatics New Zealand (HiNZ)-ALC.AX 07/10/16
ALC Alcidion to Present at TechKnow Invest Roadshow-ALC.AX 06/10/16
ALC Corporate Governance Statement-ALC.AX 03/10/16
ALC Appendix 4C for Q1 FY17-ALC.AX PRICE SENSITIVE03/10/16
ALC 30 June 2016 Annual Report to Shareholders-ALC.AX 30/09/16
ALC Appendix 4G-ALC.AX 30/09/16
ALC Alcidion Secure $525k Contract with The NT-ALC.AX PRICE SENSITIVE22/09/16
ALC Change in Director's Interest-ALC.AX 21/09/16
ALC Alcidion Product Overview Webinar-ALC.AX 14/09/16
ALC Alcidion to Present at WA Broker Meets Biotech-ALC.AX 08/09/16
ALC Alcidion to Host Product Overview Webinar-ALC.AX 08/09/16
ALC Alcidion Investor Presentation-ALC.AX 31/08/16
ALC Appendix 4E - FY16 Preliminary Final Report-ALC.AX PRICE SENSITIVE31/08/16
ALC Alcidion to Host Investor Webinar on 31 August 2016-ALC.AX 30/08/16
ALC Response to ASX Aware Query-ALC.AX PRICE SENSITIVE05/08/16
ALC Change of Director's Interest Notice - Appendix 3Y-ALC.AX 05/08/16
ALC Initial Director's Interest Notice - Appendix 3X-ALC.AX 04/08/16
ALC Alcidion to Meet with NSW Health Minister-ALC.AX 02/08/16
ALC Alcidion sign $2.35m MoU with Western Health-ALC.AX PRICE SENSITIVE01/08/16
ALC Quarterly Activities and Cashflow Reports - 30 June 2016-ALC.AX PRICE SENSITIVE29/07/16
ALC Alcidion appoint Resapp Health co-founder Brian Leedman-ALC.AX 28/07/16
ALC Professor Malcolm Pradhan presentation at Health Informatics-ALC.AX 26/07/16
ALC Buzza to present at BioShares Biotech Summit-ALC.AX 26/07/16
ALC Alcidion's CMO to present at Health Informatics Conference-ALC.AX PRICE SENSITIVE01/07/16
ALC Tasmania NICS goes live with Miya Clinic-ALC.AX 27/06/16
ALC Alcidion Develops Data Acquisition Technology for NEDA-ALC.AX PRICE SENSITIVE15/06/16
ALC FUJIFILM Partnership Delivers New Contracts-ALC.AX PRICE SENSITIVE03/06/16
ALC Response to ASX Price and Volume Query-ALC.AX PRICE SENSITIVE30/05/16
ALC Alcidion to exhibit at National AusMedTech Conference-ALC.AX 04/05/16
ALC Appendix 4C - March Quarterly-ALC.AX PRICE SENSITIVE29/04/16
ALC Alcidion Wholesale Investor Presentation-ALC.AX 29/04/16
ALC Alcidion to present at Sydney Wholesale Investor Conference-ALC.AX 29/04/16
ALC Alcidion roll out Critical Test Results Management across NT-ALC.AX PRICE SENSITIVE07/04/16
ALC Private Hospital Group set to trial Miya Patient Flow16/03/16
ALC Becoming a substantial holder29/02/16
ALC Final Director's Interest Notice - Appendix 3Z (x2)29/02/16
ALC Initial Director's Interest Notice - Appendix 3X (x4)29/02/16
ALC Becoming a substantial holder29/02/16
ALC Becoming a substantial holder29/02/16
ALC Investor Presentation26/02/16
ALC 2013, 2014, 2015 Accounts25/02/16
ALC Trading Policy25/02/16
ALC Confirmations, Capital Structure and Financial Position25/02/16
ALC Top 2025/02/16
ALC Appendix 1A and checklist25/02/16
ALC Distribution Schedule25/02/16
ALC Pre-Quotation Disclosure25/02/16
ALC ASX Notice25/02/16
ALC Reinstatement to Official Quotation 29/02/16PRICE SENSITIVE25/02/16
ALC Waiver to ASXLR 14.723/02/16
ALC Half Yearly Accounts22/02/16
ALC Quarterly Activities and Cashflow Reports - 31 Dec 201529/01/16
ALC Becoming a substantial holder
23/12/16
ALC Alcidion - Investor Relations Research
16/12/16
ALC Alcidion Executive Director Interview With FNN
14/12/16
ALC Coffs Habour Health Campus goes live with iCVIS
13/12/16PRICE SENSITIVE
ALC Alcidion Change of Share Registry Address
12/12/16
ALC Change of Director's Interest Notice
06/12/16
ALC Appendix 3B
06/12/16
ALC Final Director's Interest Notice
01/12/16
ALC Alcidion Results of AGM
29/11/16
ALC Alcidion AGM presentation
29/11/16
ALC Chairman's Letter 2016
29/11/16
ALC Company Secretary Appointment
29/11/16
ALC Details of Company Address
29/11/16
ALC Alcidion to present at ASX CEO Sessions
28/11/16
ALC Alcidion Presents at Wilsons Investor Event
24/11/16
ALC Alcidion TechKnow Investor Roadshow Interview
17/11/16
ALC Alcidion HiNZ presentation live on Website
16/11/16
ALC Alcidion Showcase at Blue Sky Annual Investor Day
16/11/16
ALC Alcidion to Release shares from escrow
10/11/16
ALC Alcidion to Meet with WA Health Minister
07/11/16
ALC Alcidion to Conduct WA Roadshow
07/11/16
ALC Notice of Annual General Meeting/Proxy Form-ALC.AX
26/10/16
ALC TechKnow Invest Roadshow Recording-ALC.AX
26/10/16
ALC Alcidion to present at Health Informatics New Zealand (HiNZ)-ALC.AX
07/10/16
ALC Alcidion to Present at TechKnow Invest Roadshow-ALC.AX
06/10/16
ALC Corporate Governance Statement-ALC.AX
03/10/16
ALC Appendix 4C for Q1 FY17-ALC.AX
03/10/16PRICE SENSITIVE
ALC 30 June 2016 Annual Report to Shareholders-ALC.AX
30/09/16
ALC Appendix 4G-ALC.AX
30/09/16
ALC Alcidion Secure $525k Contract with The NT-ALC.AX
22/09/16PRICE SENSITIVE
ALC Change in Director's Interest-ALC.AX
21/09/16
ALC Alcidion Product Overview Webinar-ALC.AX
14/09/16
ALC Alcidion to Present at WA Broker Meets Biotech-ALC.AX
08/09/16
ALC Alcidion to Host Product Overview Webinar-ALC.AX
08/09/16
ALC Alcidion Investor Presentation-ALC.AX
31/08/16
ALC Appendix 4E - FY16 Preliminary Final Report-ALC.AX
31/08/16PRICE SENSITIVE
ALC Alcidion to Host Investor Webinar on 31 August 2016-ALC.AX
30/08/16
ALC Response to ASX Aware Query-ALC.AX
05/08/16PRICE SENSITIVE
ALC Change of Director's Interest Notice - Appendix 3Y-ALC.AX
05/08/16
ALC Initial Director's Interest Notice - Appendix 3X-ALC.AX
04/08/16
ALC Alcidion to Meet with NSW Health Minister-ALC.AX
02/08/16
ALC Alcidion sign $2.35m MoU with Western Health-ALC.AX
01/08/16PRICE SENSITIVE
ALC Quarterly Activities and Cashflow Reports - 30 June 2016-ALC.AX
29/07/16PRICE SENSITIVE
ALC Alcidion appoint Resapp Health co-founder Brian Leedman-ALC.AX
28/07/16
ALC Professor Malcolm Pradhan presentation at Health Informatics-ALC.AX
26/07/16
ALC Buzza to present at BioShares Biotech Summit-ALC.AX
26/07/16
ALC Alcidion's CMO to present at Health Informatics Conference-ALC.AX
01/07/16PRICE SENSITIVE
ALC Tasmania NICS goes live with Miya Clinic-ALC.AX
27/06/16
ALC Alcidion Develops Data Acquisition Technology for NEDA-ALC.AX
15/06/16PRICE SENSITIVE
ALC FUJIFILM Partnership Delivers New Contracts-ALC.AX
03/06/16PRICE SENSITIVE
ALC Response to ASX Price and Volume Query-ALC.AX
30/05/16PRICE SENSITIVE
ALC Alcidion to exhibit at National AusMedTech Conference-ALC.AX
04/05/16
ALC Appendix 4C - March Quarterly-ALC.AX
29/04/16PRICE SENSITIVE
ALC Alcidion Wholesale Investor Presentation-ALC.AX
29/04/16
ALC Alcidion to present at Sydney Wholesale Investor Conference-ALC.AX
29/04/16
ALC Alcidion roll out Critical Test Results Management across NT-ALC.AX
07/04/16PRICE SENSITIVE
ALC Private Hospital Group set to trial Miya Patient Flow
16/03/16
ALC Becoming a substantial holder
29/02/16
ALC Final Director's Interest Notice - Appendix 3Z (x2)
29/02/16
ALC Initial Director's Interest Notice - Appendix 3X (x4)
29/02/16
ALC Becoming a substantial holder
29/02/16
ALC Becoming a substantial holder
29/02/16
ALC Investor Presentation
26/02/16
ALC 2013, 2014, 2015 Accounts
25/02/16
ALC Trading Policy
25/02/16
ALC Confirmations, Capital Structure and Financial Position
25/02/16
ALC Top 20
25/02/16
ALC Appendix 1A and checklist
25/02/16
ALC Distribution Schedule
25/02/16
ALC Pre-Quotation Disclosure
25/02/16
ALC ASX Notice
25/02/16
ALC Reinstatement to Official Quotation 29/02/16
25/02/16PRICE SENSITIVE
ALC Waiver to ASXLR 14.7
23/02/16
ALC Half Yearly Accounts
22/02/16
ALC Quarterly Activities and Cashflow Reports - 31 Dec 2015
29/01/16
refresh Created with Sketch. REFRESH
 
(20min delay)
Last
6.0¢ 		Change
-0.002(3.23%) 		Mkt cap ! $72.51M
Open High Low Value Volume
6.1¢ 6.1¢ 5.8¢ $82.90K 1.388M

Buyers (Bids)

No. Vol. Price($)
3 313786 5.9¢
 

Sellers (Offers)

Price($) Vol. No.
6.1¢ 117830 1
View Market Depth
Last trade - 12.30pm 04/12/2024 (20 minute delay) ?
Last
6.0¢ 		  Change
-0.002 ( 3.23 %)
Open High Low Volume
6.0¢ 6.2¢ 5.8¢ 380899
Last updated 12.31pm 04/12/2024 ?
ALC (ASX) Chart

Top Stories

This biotech stock raised $11M in a risk-off environment. Its Alzheimer's drug could change the game

Today, one small pill holds the potential to transform cognitive medicine by addressing conditions like depression and Alzheimer’s. 
History-making uranium sample grades and an imminent drill run. Infini Resources is poised to transform in 2025 Samples among the highest-ever-graded uranium soil samples recorded in mineral exploration history, and an imminent drill run.
Breaking news: New opportunities for investors & companies - HotCopper opens to capital raising! Companies can now raise capital through HotCopper! It’s a development allowing a highly cost-effective service to ASX-listed companies, while opening new investment opportunities to investors.
Global Lithium up 13% as it joins the ranks of battery metal players pivoting to gold Global Lithium (ASX:GL1) has joined the ranks of lithium miners turning to other metals as the great lithium rerate makes uneconomic another project. On Wednesday, the company acquired Octava Minerals’ (ASX:OCT) Talga Project, prospective for gold and base metals. That play is loc...
Chris Judd's Talk Ya Book: Orthocell building on 'enormous potential' with steady growth - and US push to come On Chris Judd’s Talk Ya Book today, the AFL legend sat down with Orthocell Limited (ASX:OCC) chairman John Van Der Wielen to talk about the @overnight success” of the ASX-listed biotech company and its bright future.@We wanted to start at the top and get a st...
arrow-down-2 Created with Sketch. arrow-down-2 Created with Sketch.